Marble Harbor Investment Counsel’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.9M Sell
178,895
-3,407
-2% -$756K 4.22% 3
2025
Q4
$41.7M Sell
182,302
-1,895
-1% -$432K 4.45% 3
2025
Q3
$42.6M Sell
184,197
-899
-0.5% -$183K 4.47% 3
2025
Q2
$34.4M Sell
185,096
-2,376
-1% -$442K 3.74% 4
2025
Q1
$39.3M Sell
187,472
-3,942
-2% -$766K 4.42% 4
2024
Q4
$34M Sell
191,414
-2,388
-1% -$439K 3.75% 6
2024
Q3
$38.3M Buy
193,802
+19
+0% +$3.55K 4.19% 4
2024
Q2
$33.2M Sell
193,783
-788
-0.4% -$131K 3.91% 4
2024
Q1
$35.4M Sell
194,571
-1,199
-0.6% -$207K 4.08% 4
2023
Q4
$30.3M Sell
195,770
-7,180
-4% -$1.05M 3.73% 5
2023
Q3
$30.3M Sell
202,950
-1,112
-0.5% -$163K 3.97% 4
2023
Q2
$27.5M Sell
204,062
-860
-0.4% -$126K 3.46% 4
2023
Q1
$32.7M Sell
204,922
-455
-0.2% -$69.6K 4.23% 3
2022
Q4
$33.2M Buy
205,377
+4,025
+2% +$617K 4.47% 4
2022
Q3
$27M Sell
201,352
-1,345
-0.7% -$193K 4.13% 4
2022
Q2
$31M Sell
202,697
-53
-0% -$8.1K 4.73% 2
2022
Q1
$32.9M Sell
202,750
-2,915
-1% -$423K 4.08% 3
2021
Q4
$27.8M Sell
205,665
-220
-0.1% -$26K 3.24% 6
2021
Q3
$22.2M Buy
205,885
+1,195
+0.6% +$137K 2.99% 8
2021
Q2
$23.1M Sell
204,690
-2,070
-1% -$233K 2.98% 7
2021
Q1
$22.4M Sell
206,760
-3,225
-2% -$345K 3.06% 8
2020
Q4
$22.5M Buy
209,985
+716
+0.3% +$68.8K 3.31% 6
2020
Q3
$18.3M Sell
209,269
-5,091
-2% -$479K 3% 8
2020
Q2
$21M Sell
214,360
-7,079
-3% -$623K 3.66% 7
2020
Q1
$16.9M Sell
221,439
-1,765
-0.8% -$150K 3.32% 8
2019
Q4
$19.8M Buy
223,204
+5,036
+2% +$418K 3.12% 8
2019
Q3
$16.5M Buy
218,168
+24,145
+12% +$1.66M 2.93% 9
2019
Q2
$14.1M Buy
194,023
+1,350
+0.7% +$106K 2.44% 12
2019
Q1
$15.5M Sell
192,673
-520
-0.3% -$42.5K 2.76% 10
2018
Q4
$17.8M Sell
193,193
-806
-0.4% -$70.9K 3.56% 6
2018
Q3
$18.3M Sell
193,999
-332
-0.2% -$31.5K 3.26% 6
2018
Q2
$18M Sell
194,331
-2,568
-1% -$251K 3.43% 5
2018
Q1
$18.6M Sell
196,899
-1,721
-0.9% -$189K 3.69% 3
2017
Q4
$19.2M Sell
198,620
-1,944
-1% -$183K 3.74% 1
2017
Q3
$17.8M Sell
200,564
-68
-0% -$5.18K 3.63% 1
2017
Q2
$14.5M Sell
200,632
-1,825
-0.9% -$123K 3.15% 3
2017
Q1
$13.2M Buy
202,457
+3,042
+2% +$191K 2.88% 8
2016
Q4
$12.5M Sell
199,415
-343
-0.2% -$20.9K 2.81% 7
2016
Q3
$12.6M Sell
199,758
-2,440
-1% -$158K 2.96% 7
2016
Q2
$12.5M Sell
202,198
-1,729
-0.8% -$105K 3.04% 8
2016
Q1
$11.6M Buy
203,927
+2,870
+1% +$160K 2.88% 9
2015
Q4
$11.9M Sell
201,057
-1,865
-0.9% -$107K 3.17% 5
2015
Q3
$11M Sell
202,922
-1,244
-0.6% -$81K 3.04% 7
2015
Q2
$13.7M Sell
204,166
-1,730
-0.8% -$113K 3.5% 3
2015
Q1
$12.1M Sell
205,896
-13,239
-6% -$800K 3.02% 6
2014
Q4
$14.3M Buy
219,135
+2,032
+0.9% +$128K 3.27% 5
2014
Q3
$12.5M Sell
217,103
-7,185
-3% -$399K 3.03% 4
2014
Q2
$12.7M Buy
224,288
+3,351
+2% +$176K 3% 5
2014
Q1
$11.4M Buy
220,937
+5,039
+2% +$255K 2.94% 6
2013
Q4
$11.4M Sell
215,898
-395
-0.2% -$19.4K 3.01% 6
2013
Q3
$9.68M Sell
216,293
-2,826
-1% -$125K 2.75% 6
2013
Q2
$9.06M Buy
+219,119
New +$9.58M 2.71% 7

Other funds holding ABBV

Marble Harbor Investment Counsel's ABBV Position: Q1 2026 in Review

Marble Harbor Investment Counsel reduced its AbbVie (ABBV) stake by 1.9% in Q1 2026, selling an estimated $756K and leaving 178,895 shares worth $38.9M. The position accounts for 4.22% of the portfolio, ranked #3.

Marble Harbor Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $42.6M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Marble Harbor Investment Counsel held 178,895 shares of AbbVie worth $38.9M as of Q1 2026.
  • Marble Harbor Investment Counsel sold 3,407 AbbVie shares in Q1 2026, an estimated $756K.
  • AbbVie made up 4.22% of Marble Harbor Investment Counsel's portfolio in Q1 2026, its #3 holding.
  • Marble Harbor Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Marble Harbor Investment Counsel's AbbVie position peaked at $42.6M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Marble Harbor Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.